Home LiteratureArticle Details
PMID: 11416160 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE

Abstract

We recently have introduced the term vasculogenic mimicry to describe the unique ability of aggressive melanoma tumor cells to form tubular structures and patterned networks in three-dimensional culture, which "mimics" embryonic vasculogenic networks formed by differentiating endothelial cells. In the current study, we address the biological significance of several endothelial-associated molecules (revealed by microarray analysis) with respect to expression and function in highly aggressive and poorly aggressive human cutaneous melanoma cell lines (established from the same patient). In a comparative analysis, CD31 was not expressed by any of the melanoma cell lines, whereas TIE-1 (tyrosine kinase with Ig and epidermal growth factor homology domains-1) was strongly expressed in the highly aggressive tumor cells with a low level of expression in one of the poorly aggressive cell lines. Vascular endothelial (VE)-cadherin was exclusively expressed by highly aggressive melanoma cells and was undetectable in the poorly aggressive tumor cells, suggesting the possibility of a vasculogenic switch. Down-regulation of VE-cadherin expression in the aggressive melanoma cells abrogated their ability to form vasculogenic networks and directly tested the hypothesis that VE-cadherin is critical in melanoma vasculogenic mimicry. These results highlight the plasticity of aggressive melanoma cells and call into question their possible genetic reversion to an embryonic phenotype. This finding could pose a significant clinical challenge in targeting tumor cells that may masquerade as circulating endothelial cells or other embryonic-like stem cells.

MeSH Terms
Antigens, CD Cadherins/biosynthesis,genetics Diagnosis, Differential Endothelium, Vascular/pathology,physiology Gene Expression Regulation, Neoplastic Humans Melanoma/genetics,metabolism,pathology Neovascularization, Pathologic/genetics Tumor Cells, Cultured
Chemicals
Antigens, CD Cadherins cadherin 5
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Hendrix M J
Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242-1109, USA. mary-hendrix@uiowa.edu
Seftor E A
Meltzer P S
Gardner L M
Hess A R
Kirschmann D A
Schatteman G C
Seftor R E
References (35)
35 references, click to expand
  1. Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer.
    Int Arch Allergy Immunol. 1999 Nov;120(3):237-44 PMID: 10592470
  2. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.
    Cancer Res. 2000 Dec 15;60(24):6805-10 PMID: 11156369
  3. Mechanisms of angiogenesis and arteriogenesis.
    Nat Med. 2000 Apr;6(4):389-95 PMID: 10742145
  4. Tumor sinuses- vascular channels.
    Pathol Oncol Res. 2000;6(2):83-6 PMID: 10936781
  5. Molecular classification of cutaneous malignant melanoma by gene expression profiling.
    Nature. 2000 Aug 3;406(6795):536-40 PMID: 10952317
  6. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.
    J Clin Invest. 2000 Aug;106(4):571-8 PMID: 10953032
  7. Vascular-specific growth factors and blood vessel formation.
    Nature. 2000 Sep 14;407(6801):242-8 PMID: 11001067
  8. Developmental biology. One cell, two fates.
    Nature. 2000 Nov 2;408(6808):43, 45 PMID: 11081495
  9. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.
    Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13 PMID: 11121063
  10. Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma.
    Hum Pathol. 2000 Dec;31(12):1520-2 PMID: 11150378
  11. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer.
    Cancer Res. 2001 Jan 15;61(2):445-51 PMID: 11212228
  12. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells.
    Breast Cancer Res. 2000;2(6):417-22 PMID: 11250735
  13. Molecular determinants of ovarian cancer plasticity.
    Am J Pathol. 2001 Apr;158(4):1279-88 PMID: 11290546
  14. The growth of the blood supply to melanoma transplants in the hamster cheek pouch.
    Lab Invest. 1966 Feb;15(2):464-78 PMID: 5932611
  15. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.
    J Natl Cancer Inst. 1992 Feb 5;84(3):165-74 PMID: 1371813
  16. Classical cadherins.
    Semin Cell Biol. 1992 Jun;3(3):149-55 PMID: 1623204
  17. A novel endothelial-specific membrane protein is a marker of cell-cell contacts.
    J Cell Biol. 1992 Sep;118(6):1511-22 PMID: 1522121
  18. Specificity of cell adhesion in development: the cadherin superfamily.
    Curr Opin Genet Dev. 1992 Aug;2(4):621-4 PMID: 1525517
  19. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
    Nature. 1995 Jul 6;376(6535):70-4 PMID: 7596437
  20. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.
    N Engl J Med. 1995 Dec 28;333(26):1757-63 PMID: 7491141
  21. Tie1, a receptor tyrosine kinase essential for vascular endothelial cell integrity, is not critical for the development of hematopoietic cells.
    Oncogene. 1996 Jan 18;12(2):397-404 PMID: 8570217
  22. Cell adhesion: the molecular basis of tissue architecture and morphogenesis.
    Cell. 1996 Feb 9;84(3):345-57 PMID: 8608588
  23. Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls.
    Cancer Metastasis Rev. 1996 Jun;15(2):231-6 PMID: 8842495
  24. Mechanisms of angiogenesis.
    Nature. 1997 Apr 17;386(6626):671-4 PMID: 9109485
  25. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?
    J Clin Invest. 1997 May 1;99(9):2139-51 PMID: 9151786
  26. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies.
    Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6273-8 PMID: 9177207
  27. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Am J Pathol. 1998 Apr;152(4):855-63 PMID: 9546344
  28. Angiogenic molecules and cancer metastasis.
    In Vivo. 1998 Jan-Feb;12(1):27-34 PMID: 9575423
  29. Vascularization in the murine allantois occurs by vasculogenesis without accompanying erythropoiesis.
    Development. 1998 Nov;125(22):4507-20 PMID: 9778509
  30. Role of vascular endothelial-cadherin in vascular morphogenesis.
    Development. 1999 May;126(10):2093-102 PMID: 10207135
  31. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.
    Cell. 1999 Jul 23;98(2):147-57 PMID: 10428027
  32. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?
    Am J Pathol. 1999 Sep;155(3):675-9 PMID: 10487823
  33. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Am J Pathol. 1999 Sep;155(3):739-52 PMID: 10487832
  34. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels.
    Am J Pathol. 1999 Sep;155(3):887-95 PMID: 10487846
  35. Vasculogenic mimicry and tumor angiogenesis.
    Am J Pathol. 2000 Feb;156(2):361-81 PMID: 10666364
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-07-03
Epub
2001-00-19
Pages
8018-23
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC35460
Subset
IM
Grants
NCI NIH HHS · R37 CA059702 · United States
NCI NIH HHS · R01 CA059702 · United States
NCI NIH HHS · CA59702 · United States
NIDDK NIH HHS · DK55965 · United States
NIDDK NIH HHS · R01 DK055965 · United States
NCI NIH HHS · CA83137 · United States
NCI NIH HHS · CA80318 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com